Of the 221 patients which were evaluable for response, 29.2 percent achieved a partial response or better in the pomalidomide as well as low-dose dexamethasone arm in comparison to 7.4 percent in the pomalidomide-alone arm. Overall Response Rate was based on responses assessed by the Independent Review Adjudication Committee predicated on the European Group for Blood and Marrow Transplantation requirements. The median duration of response for sufferers in the pomalidomide plus low-dosage dexamethasone arm was 7.4 months while the median has not yet been reached for the pomalidomide alone arm.For example, as the Framingham Risk Rating is known as ‘a great progress’ in the estimation of risk , most younger individuals and practically all women are thought as low risk, despite obvious and significant differences in their actual risk aspect burden. Now, a new study reported online by Circulation suggests that many younger people defined as low risk by conventional risk stratification methods might not stay at low risk throughout their lives. The analysis included 2988 individuals under 50 years of age from the Coronary Artery Risk Advancement in Young Adults study and 1076 from the Multi-Ethnic Research of Atherosclerosis . Short-term risk was assessed according to the Framingham Risk Rating, but added to this risk assessment model were other elements indicative of a longer lifetime risk.